Cristina Larkin Spero Therapeutics, Inc. (SPRO) insider trading activity

SPRO Quotes by TradingView

Cristina Larkin is Chief Operating Officer of Spero Therapeutics, Inc.. Currently has a direct ownership of 63,581 shares of SPRO, which is worth approximately $75,661. The most recent transaction as insider was on Feb 01, 2022, when has been sold 38,014 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.6K
0% 3M change
0% 12M change
Total Value Held $75,661

Cristina Larkin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2022
BUY
Grant, award, or other acquisition
-
38,014 Added 37.42%
63,581 Common Stock
Aug 26 2021
BUY
Grant, award, or other acquisition
-
24,067 Added 48.49%
25,567 Common Stock
Dec 16 2020
SELL
Open market or private sale
$228,000 $19.0 p/Share
12,000 Reduced 88.89%
1,500 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
$70,800 $5.9 p/Share
12,000 Added 47.06%
13,500 Common Stock
CL

Cristina Larkin

Chief Operating Officer
Cambridge, MA

Track Institutional and Insider Activities on SPRO

Follow Spero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if

News

Receive news related to Spero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SPRO